Skip to content

A study to compare two different ways of giving fentanyl drugâ?? continuous infusion or intermittent doses for pain relief in newborn babies

Comparison of continuous infusion versus intermittent bolus doses of fentanyl for analgesia in neonatesâ?? An open label randomized controlled trial - FANCI trial

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2014/11/005190
Enrollment
98
Registered
2014-11-10
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Analgesia and Sedation for neonates on mechanical ventilation

Interventions

Intervention1: Intermittent doses of fentanyl: Intermittent doses of fentanyl 1 microgram/kg/dose once every 4 hours for 48 hours (minimum 24 hours) Control Intervention1: Continuous infusion of fenta

Sponsors

Institutional Review Board
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Newborn babies who are likely to require mechanical ventilation for 48 hours (minimum 24 hours)

Exclusion criteria

Exclusion criteria: 1.Major congenital anomalies/ chromosomal disorders 2.Hypoxic Ischemic encephalopathy (HIE) stage 2 or 3 3.Postoperative babies 4.Refusal of consent

Design outcomes

Primary

MeasureTime frame
To compare the exposure as concentrations of Fentanyl achieved in the serum between the two groupsTimepoint: Continuous Infusion - Fentanyl serum concentrations at: 0, 2, 8, 24 hours on DAY 1. 36 and 48 hours on DAY 2. Intermittent dosage Group - Fentanyl serum concentrations as peak and trough concentrations for dose 1 and 6â??DAY 1, peak and trough for dose 12 (or last dose, whichever is later) on DAY 2

Secondary

MeasureTime frame
To measure the exposure as Cmax (when measured) at each bolus and AUC, through the 24 hour (or 48 hour) period, using limited time points, in babies receiving intermittent bolus doses of fentanylTimepoint: Fentanyl serum concentrations as peak and trough concentrations for dose 1 and 6 on DAY 1, peak and trough for dose 12 (or last dose, whichever is later) on DAY 2;To compare the analgesic efficacy between continuous infusion and intermittent bolus doses of fentanyl using pain scoresTimepoint: Day 1 and 2 of fentanyl;To compare the side effects of fentanyl between the two groupsTimepoint: Day 1 and 2 of fentanyl;To find the inter-individual variability in serum concentrations of fentanyl in the two groups, especially the effect of gestational age on fentanyl clearanceTimepoint: Day 1 and 2 of fentanyl;To measure the exposure as Cmax (peak concentration) and area under concentration time curve (AUC 0-24 hours or AUC 0-48 hours) in babies receiving continuous infusion of fentanylTimepoint: Fentanyl serum concentrations at 0, 2, 8, 24 hours on DAY 1 and 36, 48 hours on DAY 2

Countries

India

Contacts

Public ContactAbiramalatha T

Christian Medical College, Vellore

anilkk@cmcvellore.ac.in04163073311

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 23, 2026